Rathbone Michael J, Bunt Craig R, Ogle Colin R, Burggraaf Shane, Macmillan Keith L, Pickering Kim
InterAg, 558 Te Rapa Road, PO Box 20055, Hamilton, New Zealand. mjr@interag l.co.nz
J Control Release. 2002 Dec 13;85(1-3):61-71. doi: 10.1016/s0168-3659(02)00272-9.
This paper reports experiments conducted to research, develop and clinically evaluate an injection molded intravaginal insert manufactured from the biodegradable polyester poly(epsilon-caprolactone). The study demonstrated that it is possible to engineer poly(epsilon-caprolactone) into a shape that is well retained, and can be used as a platform for the controlled delivery of progesterone via the vagina of cows. Field evaluation showed that the poly(epsilon-caprolactone) intravaginal inserts containing 10% (w/w) progesterone were at least as effective clinically as the commercially available CIDR intravaginal insert.